Kim, Y. ., Yang, J. ., Yoon, J. ., Jo, S. ., Ahn, H. ., Song, K. ., … Kim, I. . (2018). A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT). The British Journal of Dermatology. https://doi.org/10.1111/bjd.16368 (Original work published 2018)